Advancing the Field of Breast Cancer Care
ONCOLOGY® recently sat down with Joyce A. O’Shaughnessy, MD, to discuss the recent trends in breast cancer treatment and the avalanche of agents moving through the development pipeline that have the potential to redefine the accepted standards of care.
PALB2 Germline Mutations Moderately Increased Risk of PALB2-Related Breast Cancer in China
This study analyzed the full prevalence and spectrum of partner and localizer ...